Page last updated: 2024-10-28

hydroxychloroquine and Leukemia, Lymphoid

hydroxychloroquine has been researched along with Leukemia, Lymphoid in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastin, R1
Christol, D1
Kernbaum, S1
Frottier, J1
Azizi, P1

Other Studies

1 other study available for hydroxychloroquine and Leukemia, Lymphoid

ArticleYear
[Chronic lymphoid leukemia followed by periarteritis nodosa].
    Annales de medecine interne, 1973, Volume: 124, Issue:2

    Topics: Biopsy; Blood Cell Count; Blood Platelets; Dietary Carbohydrates; Humans; Hydroxychloroquine; Leukem

1973